We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+7.1%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.69B
AUM Growth
+$214M
Cap. Flow
+$72.4M
Cap. Flow %
2.69%
Top 10 Hldgs %
36.8%
Holding
3,484
New
256
Increased
1,490
Reduced
872
Closed
231
Avg Time Held Equity + Options
2.8 years
Top 10 Avg Time Held Equity + Options
2.2 years
Top 20 Avg Time Held Equity + Options
2.1 years
Avg Time Held Equity only
2.8 years
Top 10 Avg Time Held Equity only
2.2 years
Top 20 Avg Time Held Equity only
2.1 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 51.24%
2 Technology 16.87%
3 Financials 7.26%
4 Healthcare 6.41%
5 Consumer Discretionary 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AKTS icon
3326
DELISTED
Akoustis Technologies Inc
AKTS
$0 ﹤0.01%
30
-5
-14% -$37
2020 Q4
4 quarters
AXNX icon
3327
DELISTED
Axonics, Inc. Common Stock
AXNX
$0 ﹤0.01%
5
+1
+25% +$61
2021 Q3
1 quarter
STER icon
3328
DELISTED
Sterling Check Corp. Common Stock
STER
– –
-100
Closed -$3K –
PETQ icon
3329
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
– –
-172
Closed -$4K –
ASTSW icon
3330
DELISTED
AST SpaceMobile, Inc. Warrant
ASTSW
$0 ﹤0.01%
151
– –
2021 Q2
2 quarters
MKFG.WS icon
3331
DELISTED
Markforged Holding Corporation Warrants, each whole warrant exercisable to purchase one-tenth (1/10th) of a share of Common Stock at an exercise price of $115.00 per share
MKFG.WS
$0 ﹤0.01%
250
– –
2021 Q3
1 quarter
AMK icon
3332
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$0 ﹤0.01%
7
-1
-13% -$26
2021 Q3
1 quarter
DNA.WS icon
3333
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
– –
-400
Closed -$1K –
MORF icon
3334
DELISTED
Morphic Holding, Inc. Common Stock
MORF
– –
-76
Closed -$4K –
VBIV icon
3335
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$0 ﹤0.01%
+3
New +$253
2021 Q4
0 quarters
CONN icon
3336
DELISTED
Conn's Inc.
CONN
– –
-19
Closed – –
MCBC icon
3337
DELISTED
Macatawa Bank Corp
MCBC
$0 ﹤0.01%
31
– –
2020 Q2
6 quarters
CERE icon
3338
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$0 ﹤0.01%
+9
New +$318
2021 Q4
0 quarters
BHIL icon
3339
DELISTED
Benson Hill, Inc.
BHIL
– –
-29
Closed -$7K –
DMTK icon
3340
DELISTED
DermTech, Inc. Common Stock
DMTK
– –
-700
Closed -$22K –
BIOL icon
3341
DELISTED
Biolase, Inc.
BIOL
– –
0
– –
2021 Q3
1 quarter
THMO icon
3342
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
– –
0
– –
2019 Q2
10 quarters
NURO icon
3343
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$0 ﹤0.01%
1
– –
2021 Q3
1 quarter
AFIB icon
3344
DELISTED
Acutus Medical Inc
AFIB
$0 ﹤0.01%
129
+117
+975% +$659
2021 Q3
1 quarter
FIF
3345
DELISTED
FIRST TRUST ENERGY INFRASTRUCTURE FUND
FIF
$0 ﹤0.01%
1
– –
2020 Q2
6 quarters
NXTP
3346
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
$0 ﹤0.01%
+1
New +$29
2021 Q4
0 quarters
KNTE
3347
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
– –
-199
Closed -$5K –
PGTI
3348
DELISTED
PGT, Inc.
PGTI
– –
-11
Closed – –
MIXT
3349
DELISTED
MIX TELEMATICS LIMITED
MIXT
– –
-49
Closed -$1K –
KRTX icon
3350
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$0 ﹤0.01%
+1
New +$129
2021 Q4
0 quarters

Similar funds

Parallel Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Parallel Advisors held 3,484 positions worth $2.69B, up 8.6% from $2.48B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors's Q4 2021 filing shows 256 new, 1,490 increased, 872 reduced and 231 closed positions. Its largest new stake was Payoneer: 1,784,455 shares worth $13.1M. The largest sale was iShares US Treasury Bond ETF, an estimated $17.7M.

By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 52% a quarter earlier, followed by Technology and Financials.

  • Parallel Advisors's largest Q4 2021 buy was Payoneer: 1,784,455 shares worth $13.1M.
  • Parallel Advisors added most to iShares Core MSCI EAFE ETF in Q4 2021, an estimated $29.6M increase.
  • Parallel Advisors's biggest Q4 2021 reduction was iShares US Treasury Bond ETF, cutting an estimated $17.7M.
  • Parallel Advisors fully exited FTAC Olympus Acquisition Corp. Class A Ordinary Shares in Q4 2021, selling an estimated $15.5M.
  • Parallel Advisors's ten largest holdings make up 37% of its $2.69B portfolio in Q4 2021.
  • Parallel Advisors opened 256 new positions and closed 231 in Q4 2021.
  • Parallel Advisors's portfolio value rose 8.6% quarter-over-quarter to $2.69B.

Based on Parallel Advisors's 13F filing for Q4 2021, filed 20 Jan 2022.